ATRS
Antares Pharma, Inc.
ATRS
ATRS
Delisted
ATRS was delisted on the 23rd of May, 2022.
160 hedge funds and large institutions have $312M invested in Antares Pharma, Inc. in 2019 Q4 according to their latest regulatory filings, with 38 funds opening new positions, 57 increasing their positions, 40 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
19% more funds holding
Funds holding: 135 → 160 (+25)
57% less call options, than puts
Call options by funds: $1.03M | Put options by funds: $2.42M
Holders
160
Holding in Top 10
2
Calls
$1.03M
Puts
$2.42M
Top Buyers
| 1 | +$8.05M | |
| 2 | +$7.98M | |
| 3 | +$4.78M | |
| 4 |
Two Sigma Advisers
New York
|
+$4.43M |
| 5 |
SIG
Sargent Investment Group
Bethesda,
Maryland
|
+$3.6M |
Top Sellers
| 1 | -$18.8M | |
| 2 | -$4.47M | |
| 3 | -$1.86M | |
| 4 |
SAM
Silvercrest Asset Management
New York
|
-$1.83M |
| 5 |
Northern Trust
Chicago,
Illinois
|
-$1.36M |